Clinical Trials
Closed
Phase
SWOG Clinical Trial Number
SWOG-8700
Consolidation Therapy with High-Dose Cyclophosphamide and Total Body Irradiation, Followed by Autologous Marrow Infusion in Metastatic Breast Cancer, Phase II
Research Committee(s)
Breast Cancer
Activated
04-01-1988
Closed
01-01-1989
Closed
Phase
Accrual
57%
SWOG Clinical Trial Number
SWOG-8735
Closed
Phase
Accrual
23%
Published
SWOG Clinical Trial Number
SWOG-8706
A Prospective Study of Three Post-Remission Therapies in Adult Acute Nonlymphocytic Leukemia: Allogeneic Transplantation vs. Autologous Transplantation vs. Consolidation Chemotherapy
Research Committee(s)
Leukemia
Activated
04-01-1988
Closed
12-15-1990
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8733
Evaluations of Operable Bladder Cancer Patients with Pre-Operative Irradiation + 5-FU and Inoperable Patients With Irradiation + 5-FU Alone, Phase II, A Pilot Study for Patients Ineligible for SWOG-8710
Research Committee(s)
Genitourinary Cancer
Activated
04-01-1988
Closed
02-15-1997
Closed
Phase
Accrual
92%
Published
SWOG Clinical Trial Number
SWOG-8810
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8736 (INT-0093)
Treatment of Localized Non-Hodgkin's Lymphoma: Comparison of Chemotherapy (CHOP) to Chemo-therapy Plus Radiation Therapy
Research Committee(s)
Lymphoma
Activated
03-15-1988
Closed
06-15-1995
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
SWOG-8515
Reactivated (unfavorable histology only): 4/15/90, Temporarily Closed (unfavorable histology only): 11/1/89 Evaluation of Menogaril (NSC-269148) in Non-Hodgkin's Lymphoma
Research Committee(s)
Lymphoma
Activated
03-15-1988
Closed
12-15-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8715
Evaluation of Amonafide in Advanced Sarcomas
Activated
03-01-1988
Closed
02-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8731
Ifosfamide and Mesna in Malignant Mesothelioma
Activated
03-01-1988
Closed
07-15-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8714
Evaluation of Amonafide in Colorectal Carcinoma
Activated
03-01-1988
Closed
05-01-1989
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8732
Evaluation of Amonafide in Endometrial Carcinoma
Activated
03-01-1988
Closed
03-01-1991
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-8734
Phase ll Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Stomach
Research Committee(s)
Gastrointestinal Cancer
Activated
03-01-1988
Closed
01-01-1990
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8729
Phase II Trial of Low Dose PALA and High Dose 5-FU as a Short Term Infusion in the Treatment of Adeno-carcinoma of the Pancreas
Activated
03-01-1988
Closed
01-01-1990
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
SWOG-8790 (INT-0083) (GOG-133)
A Randomized Trial of Adjuvant Intraperitoneal Recombinant Interferon Alpha-2 in Stage III Ovarian Carcinoma in Patients Who Have No Evidence of Disease After Surgery and Chemotherapy
Research Committee(s)
Gynecologic Cancer
Activated
03-01-1988
Closed
06-15-1999
Closed
Phase
Accrual
20%
SWOG Clinical Trial Number
SWOG-8621
Chemo-Hormonal Therapy of Postmenopausal Receptor-Positive Breast Cancer
Activated
02-01-1988
Closed
08-01-1991
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8728
Evaluation of Didemnin B in Metastatic Adenocarcinoma of the Kidney
Activated
01-01-1988
Closed
02-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8716
Evaluation of Amonafide in Renal Cell Carcinoma
Activated
11-01-1987
Closed
11-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8722
Evaluation of Amonafide in Adenocarcinoma of the Prostate
Activated
11-01-1987
Closed
04-01-1989
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
SWOG-8640
Evaluation of Didemnin-B or Trimetrexate in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix
Activated
10-01-1987
Closed
07-15-1990
Closed
Phase
Accrual
69%
Published
SWOG Clinical Trial Number
SWOG-8721
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
09-01-1987
Closed
09-01-1991